Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06603285

A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin

Sponsor: Excelsior

View on ClinicalTrials.gov

Summary

This is a multi-center, single-arm, prospective study to enroll patients diagnosed as pulmonary arterial hypertension. The objective in this study is to observe the efficacy and safety of treprostinil in subjects with pulmonary arterial hypertension.

Official title: A Multi-center, Prospective Study to Observe the Safety, Tolerability, and Efficacy of Remodulin® in Patients With Pulmonary Arterial Hypertension

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

20

Start Date

2025-10-16

Completion Date

2029-12-31

Last Updated

2025-08-15

Healthy Volunteers

No

Interventions

DRUG

Treprostinil

sc/iv continuously